P. Markus Deckert
Impact in
-
- Cancer Immunotherapy and Biomarkers
- CAR-T cell therapy research
- Neurology top 10%
- Autoimmune Neurological Disorders and Treatments
Papers in
-
- Glycosylation and Glycoproteins Research 8
-
- Monoclonal and Polyclonal Antibodies Research 14
- Co-authors
- H. Poliwoda (8 shared papers)Jens Atzpodien (7 shared papers)Hartmut Kirchner (7 shared papers)Martin Fenner (3 shared papers)Hendrik Fuchs (6 shared papers)Enrique Lopez Hänninen (4 shared papers)Christopher Bachran (3 shared papers)Guido Reifenberger (1 shared paper)
- Journals
- International Journal of Oncology (3 papers)Oncology (2 papers)International Journal of Cancer (2 papers)Journal of Clinical Oncology (2 papers)Cancer Biotherapy and Radiopharmaceuticals (2 papers)
- Partner nations
- GermanyUnited StatesSwitzerland
In The Last Decade
P. Markus Deckert
42 papers receiving 829 citations
Peers
Comparison fields: 5 of 89
- Oncology 202
- Neurology 112
- Radiology, Nuclear Medicine and Imaging 136
- Immunology 127
- Biotechnology 50
Countries citing papers authored by P. Markus Deckert
This map shows the geographic impact of P. Markus Deckert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Markus Deckert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Markus Deckert more than expected).
Fields of papers citing papers by P. Markus Deckert
This network shows the impact of papers produced by P. Markus Deckert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Markus Deckert. The network helps show where P. Markus Deckert may publish in the future.
Co-authors
The 25 scholars most cited alongside P. Markus Deckert, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1993 | 120 | |
| 2 | 2000 | 100 | |
| 3 | 2010 | 77 | |
| 4 | 2009 | 71 | |
| 5 | 1989 | 62 | |
| 6 | 1999 | 54 | |
| 7 | 2003 | 33 | |
| 8 | 2001 | 32 | |
| 9 | 2017 | 31 | |
| 10 | 1993 | 30 | |
| 11 | 2009 | 24 | |
| 12 | European studies of interleukin-2 in metastatic renal cell carcinoma. | 1993 | 24 |
| 13 | 2000 | 22 | |
| 14 | 2007 | 21 | |
| 15 | 2005 | 20 | |
| 16 | 2008 | 13 | |
| 17 | 2004 | 13 | |
| 18 | 2019 | 12 | |
| 19 | 1996 | 12 | |
| 20 | 2007 | 11 |
About P. Markus Deckert
P. Markus Deckert is a scholar working on Molecular Biology, Radiology, Nuclear Medicine and Imaging, Oncology, Neurology and Immunology, having authored 48 papers that have together received 873 indexed citations. Recurring topics across this work include Monoclonal and Polyclonal Antibodies Research (14 papers), Glycosylation and Glycoproteins Research (8 papers), CNS Lymphoma Diagnosis and Treatment (4 papers), Immunotherapy and Immune Responses (4 papers), Sarcoma Diagnosis and Treatment (4 papers), Cancer Immunotherapy and Biomarkers (4 papers), Lymphoma Diagnosis and Treatment (4 papers) and Cancer Research and Treatments (4 papers). The work is most often cited by research in Oncology (202 citations), Neurology (112 citations), Radiology, Nuclear Medicine and Imaging (136 citations), Immunology (127 citations) and Biotechnology (50 citations). P. Markus Deckert has collaborated with scholars based in Germany, United States and Switzerland. Frequent co-authors include H. Poliwoda, Jens Atzpodien, Hartmut Kirchner, Martin Fenner, Hendrik Fuchs, Enrique Lopez Hänninen, Christopher Bachran, Guido Reifenberger, W. Wechsler and Reinhard Prior. Their work appears in journals such as International Journal of Oncology, Oncology, International Journal of Cancer, Journal of Clinical Oncology and Cancer Biotherapy and Radiopharmaceuticals.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.